Our Mission is to make MABR the Mainstream Choice for Wastewater Aeration
Conventional Wastewater Treatment Is Very Wasteful
Conventional wastewater treatment consumes between 2-3% of a nation’s total electricity production. This is due to a 100 year reliance on bubble diffusion for conventional secondary treatment which will typically suffer energy losses of 65-70% in the process because of the oxygen transfer limitations in the bubble aeration process.
MABR Does Not Have The Same Limitations
The Membrane Aerated Biofilm Reactor (MABR) does not have any such limitations as it does not rely on bubbles to deliver oxygen to the biology that breaks down the wastewater. This makes MABR 4X more energy efficient than Conventional Activated Sludge (CAS) and 10X more efficient than Moving Bed Bioflm Reactors (MBBR).
At OxyMem, we are providing products and services which continue to challenge the inefficiencies of the past 100 years. In doing so we enable our customers to build and operate energy efficient biological wastewater treatment plants and allowing them to get closer to energy neutral wastewater treatment goals.
First to Deliver MABR Innovation
OxyMem is recognised as developing the world’s first commercially available Membrane Aerated Biofilm Reactor (MABR). A leading edge technology for the wastewater treatment market.
We are committed to maintaining the level of technical excellence that first allowed us to deliver the MABR to the market in 2014. We will continue to work with our partners and customers to advance innovation around this smart aeration solution so as to remain the recognised pioneer of Membrane Aerated Biofilm Reactor.
OxyMem is Committed To:
→ Cost Leadership
→ Quality & Service excellence
→ Exceptional Product Performance
→ Long Term, Value-Added Relationships with our Customers and Strategic Partners
→ Continuous Research, Development and Innovation to Meet the Needs of our Customers and the Marketplace
→ Best Performance at Lowest Cost